BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18484660)

  • 1. Study of serum argininosuccinate lyase determination for diagnosis of liver diseases.
    Feng JF; Chen TM; Wen YA; Wang J; Tu ZG
    J Clin Lab Anal; 2008; 22(3):220-7. PubMed ID: 18484660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of serum argininosuccinate lyase in diagnosing liver diseases].
    Feng JF; Chen TM; Tu ZG
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):521-4. PubMed ID: 17669242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
    Kukuk GM; Schaefer SG; Fimmers R; Hadizadeh DR; Ezziddin S; Spengler U; Schild HH; Willinek WA
    Eur Radiol; 2014 Oct; 24(10):2482-90. PubMed ID: 25030459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the damage of liver in patients with SARS].
    Guan YJ; Tang XP; Yin CB; Yi ZQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):267-70. PubMed ID: 15132787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
    Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
    Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac hepatopathy before and after heart transplantation.
    Dichtl W; Vogel W; Dunst KM; Grander W; Alber HF; Frick M; Antretter H; Laufer G; Pachinger O; Pölzl G
    Transpl Int; 2005 Jun; 18(6):697-702. PubMed ID: 15910296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the optimal cut-off values for liver enzymes in diagnosing blunt liver injury.
    Koyama T; Hamada H; Nishida M; Naess PA; Gaarder C; Sakamoto T
    BMC Res Notes; 2016 Jan; 9():41. PubMed ID: 26809874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the upper cut-off values of serum alanine aminotransferase and aspartate aminotransferase in Chinese.
    Zhang P; Wang CY; Li YX; Pan Y; Niu JQ; He SM
    World J Gastroenterol; 2015 Feb; 21(8):2419-24. PubMed ID: 25741150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum arginino-succinate lyase: observations on the sensitivity and specificity of this test in the detection of minimal hepatocellular damage.
    Sims FH; Rautanen P
    Clin Biochem; 1975 Jun; 8(3):213-21. PubMed ID: 1149220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of Traditional Biomarkers of Liver Injury After an Ultramarathon at Altitude.
    Tirabassi JN; Olewinski L; Khodaee M
    Sports Health; 2018; 10(4):361-365. PubMed ID: 29558239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats.
    Tonomura Y; Kato Y; Hanafusa H; Morikawa Y; Matsuyama K; Uehara T; Ueno M; Torii M
    J Appl Toxicol; 2015 Feb; 35(2):165-72. PubMed ID: 25186495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of the liver function test in differential diagnosis of infantile hepatitis syndrome and biliary atresia].
    Chu B; Jiang LR; Zhou S; Xu YZ; Zhang B; Deng ZH
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):953-6. PubMed ID: 20113595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha-glutathione S-transferase as a sensitive marker of hepatocellular damage in patients with cystic fibrosis.
    Sídlová K; Skalická V; Kotaska K; Pechová M; Chada M; Bartosová J; Hríbal Z; Nevoral J; Vávrová V; Průsa R
    Physiol Res; 2003; 52(3):361-5. PubMed ID: 12790769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B.
    Hung KY; Lee KC; Yen CJ; Wu KD; Tsai TJ; Chen WY
    Nephrol Dial Transplant; 1997 Jan; 12(1):180-3. PubMed ID: 9157333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Center Experience With Liver Transplant Using Donors With Very High Transaminase Levels.
    Martins PN; Rawson A; Movahedi B; Brüggenwirth IMA; Dolgin NH; Martins AB; Mahboub P; Bozorgzadeh A
    Exp Clin Transplant; 2019 Aug; 17(4):498-506. PubMed ID: 30119618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of twelve-hour preprandial and two-hour postprandial serum bile acids concentrations for diagnosis of hepatobiliary disease in dogs.
    Center SA; ManWarren T; Slater MR; Wilentz E
    J Am Vet Med Assoc; 1991 Jul; 199(2):217-26. PubMed ID: 1890031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.
    Li B; Zhang L; Zhang Z; Yan G; Zhu L; Lu W; Yu H
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):218-223. PubMed ID: 30277926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
    Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of biochemical liver function tests in relation to age among steady state sickle cell anemia patients.
    Akuyam SA; Abubakar A; Lawal N; Yusuf R; Aminu SM; Hassan A; Musa A; Bello AK; Yahaya IA; Okafor PA
    Niger J Clin Pract; 2017 Nov; 20(11):1428-1433. PubMed ID: 29303127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis.
    Kayadibi H; Gültepe M; Yasar B; Ince AT; Ozcan O; Ipcioglu OM; Kurdas OO; Bolat B; Benek YZ; Guveli H; Atalay S; Ozkara S; Keskin O
    Dig Dis Sci; 2009 Aug; 54(8):1764-71. PubMed ID: 18989777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.